ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 208734 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 208734; 2) Community: the network communities that were significantly associated with the response to NSC 208734; 3) Molecule: the relationships between components within communities and NSC 208734; 4) MDR: the compounds that were significantly associated with the NSC 208734.

NSC Compound Enrichment Correlation
NSC 740 Methotrexate 0.0342636096654271 0.45246018
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0342636096654271 0.32992033
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.0342636096654271 0.54187613
NSC 756053 Null 0.0342636096654271 -0.29694093
NSC 109834 Null 0.0342636096654276 0.39630463
NSC 117274 Null 0.0342636096654276 -0.025453934
NSC 119875 Cisplatin 0.0342636096654276 0.27691067
NSC 144055 Picolinaldehyde, 5-hydroxy-, thiosemicarbazone, acetate (ester) (8CI) 0.0342636096654276 0.19550067
NSC 15309 2,5-Cyclohexadiene-1,4-dione, 2,5-dimethyl- (9CI) 0.0342636096654276 0.11039154
NSC 258812 N,N-Dimethyldaunomycin hydrochloride 0.0385203205529756 0.6256068
Total:69  Current:52    [First] [Prev] [Next] [Last]